Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years

INTRODUCTION: The Human T-lymphotropic virus type 1 (HTLV-1) was the first described human retrovirus. It is currently estimated that around 5 to 10 million people worldwide are infected with this virus. Despite its high prevalence, there is still no preventive vaccine against the HTLV-1 infection....

Descripción completa

Detalles Bibliográficos
Autores principales: Santana, Carolina Souza, Andrade, Felipe de Oliveira, da Silva, Greice Carolina Santos, Nascimento, Jéssica Oliveira de Souza, Campos, Raissa Frazão, Giovanetti, Marta, Santos, Luciane Amorim, Gois, Luana Leandro, Alcantara, Luiz Carlos Júnior, Barreto, Fernanda Khouri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968880/
https://www.ncbi.nlm.nih.gov/pubmed/36860854
http://dx.doi.org/10.3389/fimmu.2023.1073779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968880/
https://www.ncbi.nlm.nih.gov/pubmed/36860854
http://dx.doi.org/10.3389/fimmu.2023.1073779

Ejemplares similares